BeOne Medicines
Maryline IVA is currently the Head of Corporate Affairs for Europe at BeiGene, overseeing Communications, Patient Advocacy, and Public Affairs since May 2022. In this role, Maryline leads the European Corporate Affairs team and develops strategies for various stakeholders, including media and patient organizations. Prior to BeiGene, Maryline served as the Worldwide Commercialization Lead for Multiple Myeloma at Bristol Myers Squibb, where responsibilities included managing commercial product strategies for hematology in ex-US markets. Earlier experience includes significant communication roles at Celgene, where Maryline led brand communications for hematology and immunology, and at Stallergenes Greer, focusing on global communication strategies in respiratory allergies. Maryline's educational background includes a degree in Business Leadership from IMD and DESS degrees in Communication and Marketing from Université Paris-Est Marne-la-Vallée and CELSA Paris-Sorbonne.
This person is not in any teams
This person is not in any offices
BeOne Medicines
36 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.